Walsky Investment Management, Inc.

Position in LLY — ELI LILLY & Co

CIK 2110046 WYOMISSING, PA

Position in LLY

as of Jun 30, 2026 · filed Aug 14, 2026 Compact

Position Value

$6,476,922

+$1,294,019 QoQ

Shares Held

5,400

-4.2% QoQ

Ownership

0.001%

of shares outstanding

% of Portfolio

6.03%

of 13F equity value

Holder Rank

#1,521

of 4,604 holders

Holding Since

Dec 2025

3 quarters on record

Voting authority Sole 0% Shared 0% None 100%

Healthcare · as of Jun 30, 2026

Walsky Investment Management, Inc. holds $15,842,469 across 5 Drug Manufacturers - General names. LLY ranks #1 (40.9% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	LLY	ELI LILLY & Co This page	5,400	$6,476,922
2	JNJ	Johnson & Johnson	16,077	$4,083,075
3	MRK	Merck & Co., Inc.	16,605	$2,133,742
4	NVS	Novartis AG	10,507	$1,646,657
5	AMGN	Amgen Inc	4,148	$1,502,073

3 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$6,476,922	5,400	-4.2%	Shares	Sole	2026-08-14
2026-03-31	$5,182,903	5,635	+6.5%	Shares	Sole	2026-05-15
2025-12-31	$5,685,057	5,290	—	Shares	Sole	2026-02-10
No filing history on record for this holder in this stock.